Tivic Health Systems, Inc. Share Price

Equities

TIVC

US8887052095

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 02:00:00 27/04/2024 am IST 5-day change 1st Jan Change
1.04 USD -2.80% Intraday chart for Tivic Health Systems, Inc. -6.31% -42.22%
Sales 2022 1.84M 153M Sales 2023 1.18M 98.05M Capitalization 2.64M 220M
Net income 2022 -10M -834M Net income 2023 -8M -667M EV / Sales 2022 1.74 x
Net cash position 2022 2.99M 249M Net cash position 2023 3.03M 252M EV / Sales 2023 -0.33 x
P/E ratio 2022
-0.61 x
P/E ratio 2023
-0.17 x
Employees 9
Yield 2022 *
-
Yield 2023
-
Free-Float 98.58%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.80%
1 week-6.31%
Current month-16.80%
1 month-13.33%
3 months-22.39%
6 months-23.53%
Current year-42.22%
More quotes
1 week
0.99
Extreme 0.99
1.18
1 month
0.99
Extreme 0.99
1.38
Current year
0.99
Extreme 0.99
2.24
1 year
0.99
Extreme 0.99
23.79
3 years
0.99
Extreme 0.99
650.00
5 years
0.99
Extreme 0.99
650.00
10 years
0.99
Extreme 0.99
650.00
More quotes
Managers TitleAgeSince
Founder 56 22/16/22
Director of Finance/CFO 52 28/23/28
Chief Tech/Sci/R&D Officer 40 01/19/01
Members of the board TitleAgeSince
Chairman 77 16/19/16
Director/Board Member 64 16/19/16
Founder 56 22/16/22
More insiders
Date Price Change Volume
26/24/26 1.04 -2.80% 13,979
25/24/25 1.07 -3.60% 45,989
24/24/24 1.11 -1.71% 26,801
23/24/23 1.129 -3.48% 6,321
22/24/22 1.17 +5.41% 5,165

Delayed Quote Nasdaq, April 27, 2024 at 02:00 am IST

More quotes
Tivic Health Systems, Inc. is a commercial-stage health tech company advancing the field of bioelectronic medicine. The Company’s patented technology platform leverages stimulation on the trigeminal, sympathetic, and vagus nerve structures. Its non-invasive and targeted approach to the treatment of inflammatory chronic health conditions is intended to give consumers and providers drug-free therapeutic solutions with high safety profiles, low risk, and broad applications. The Company’s first commercial product, ClearUP, is an FDA approved handheld bioelectronic sinus device. ClearUP is clinically proven, doctor-recommended, and available through online retailers and commercial distributors. ClearUP is sold in the U.S. directly to consumers on various platforms and through reseller channels. The Company is also focused on its intellectual property (IP) portfolio and research programs related to vagus nerve stimulation to expand its applications in non-invasive bioelectronic medicine.
More about the company

Quarterly revenue - Rate of surprise